AOD9604 10AD 10mg*10vials

AOD9604 10AD 10mg x 10 Vials

Product Overview

AOD9604 10AD is the flagship high-activity version of the AOD9604 lipolysis peptide series, representing a comprehensive upgrade from the 2AD and 5AD generations. Utilizing 10AD ultra-optimized molecular reconstruction technology, this version supports highest fat-targeting affinity, superior anti-degradation stability, and fully saturated lipolysis activity research, surpassing all conventional AOD9604 and lower AD versions research. Its high 10mg single-vial concentration supports high-dose gradient efficacy studies, extremely refractory fat metabolism modeling, long-term lipid remodeling validation, and high-standard preclinical boundary mechanism exploration. It serves as a top-quality core research ingredient for advanced research in high-end lipid metabolism and severe obesity.

Core Research Functions

Comprehensive Targeted Lipolysis Regulatory Effect and Endocrine Balance Appetite Related Studies: Supports comprehensive targeted lipolysis regulatory effect research, endocrine balance and appetite interference related studies.

Adipocyte Catabolism Cascade Effective Activation and Deep Visceral Fat Deep Oxidative Decomposition: Supports adipocyte catabolism cascade effective activation research, deep visceral fat, refractory subcutaneous fat, and long-term accumulated adipose tissue deep oxidative decomposition achievement studies.

Excessive Adipocyte Proliferation and Lipid Deposition Significant Inhibition: Supports excessive adipocyte proliferation and lipid deposition significant inhibition research, lipid metabolism disorders comprehensive remodeling achievement studies.

Saturated High Efficiency and Extremely Significant Experimental Phenotypes: Supports saturated high efficiency, extremely significant experimental phenotypes, and durable metabolic intervention effects research compared to low- and medium-dose versions of 2AD and 5AD.

Severe Refractory Obesity and Deep Lipid Metabolism Disorders Correction Research: Supports severe refractory obesity, deep lipid metabolism disorders correction, high-dose adipose browning mechanism, and extreme metabolic intervention thresholds validation advanced research, providing high precision highly reproducible stable data for leading preclinical lipid metabolism studies.

AOD9604 10AD supports comprehensive targeted lipolysis regulatory effect research, endocrine balance and appetite interference related studies. In advanced laboratory studies, it supports adipocyte catabolism cascade effective activation research, deep visceral fat, refractory subcutaneous fat, and long-term accumulated adipose tissue deep oxidative decomposition achievement studies. Compared to the low- and medium-dose versions of 2AD and 5AD, 10AD supports saturated high efficiency, extremely significant experimental phenotypes, and durable metabolic intervention effects research. It provides high precision highly reproducible stable data for leading preclinical lipid metabolism studies.

Core Product Advantages

Ultimate Comprehensive Optimized Structure of 10AD: Based on 5AD technology, it employs top-tier iterative molecular reconstruction technology to support target binding activity maximization research, ultra-low non-specific adsorption achievement research, and excellent anti-attenuation properties possession research. Lipid breakdown efficiency reaches the upper limit of the series, with experimental results showing a significant difference compared to the 2AD and 5AD versions research.

10mg High Concentration: Twice the concentration of 5AD and five times that of 2AD, supporting high-dose gradient screening, extreme fat intervention models, and large-scale repeated validation experiments matching research, low-dose efficacy limitations caused data errors related elimination research.

Pure Independent Lipid Metabolism Mechanism: Supports lipid metabolism pathway strict targeting research, food intake, hormone levels, or basic physiological functions affecting related studies, achieving pure precise efficient lipid metabolism intervention research, suitable for high-precision mechanism research.

Pharmaceutical-Grade Full-Lock Lyophilization Process: Aseptic vacuum lyophilization supports peptide inherent activity stable retention research. Each batch undergoes complete HPLC high-purity testing and is accompanied by a complete Certificate of Analysis COA, supporting ultra-low impurity content and batch-to-batch variation related research.

Standard 10-Bottle Premium Packaging: Integrated aseptic packaging, suitable for long-term strategic laboratory storage, advanced preclinical drug development, key academic research projects, and large-scale global wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 10mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis COA.